SPOP and prostate carcinoma: When considering mutations in IDC-P beyond the aforementioned SPOP mutation, which is present in 17% to 29% of IDC-P cases but found in only 10% to 11% of all prostate cancer cases, IDC-P shows a higher prevalence of mutations in genes associated with prostate cancer aggressiveness.